Succinylated gelatin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Succinylated gelatin is a plasma volume expander indicated alone or in combination with blood transfusions.

Generic Name
Succinylated gelatin
DrugBank Accession Number
DB16568
Background

Not Available

Type
Small Molecule
Groups
Experimental
Synonyms
  • Gelatin succinate
  • Gelatin, succinated
  • Modified fluid gelatin

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Therapies
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
GELOFUSINE INFUSIONSuccinylated gelatin (40 g/1000ml) + Sodium chloride (7.01 g/1000ml)InjectionIntravenousB. BRAUN SINGAPORE PTE LTD1995-05-12Not applicable

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
68915-24-2
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
  1. AIFA: Gelofusine (Succinylated Gelatin) Intravenous Injection [Link]
RxNav
52853

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Unknown StatusDiagnosticBlood Viscosity1
3CompletedTreatmentHypovolaemia2
2CompletedPreventionBody Fluid Retention1
1CompletedTreatmentMedullary Thyroid Cancer (MTC)1
1, 2CompletedBasic ScienceDiabetes Mellitus / Diabetes Mellitus, Noninsulin Dependent1
Not AvailableCompletedNot AvailablePatients Undergoing Liver Transplantation1
Not AvailableCompletedNot AvailableTreatment of Hypovolemia and Shock1
Not AvailableUnknown StatusTreatmentHemorrhage, Surgical / Platelet disorders / Total Hip Replacements1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntravenous
InjectionIntravenous7.01 g/1000ml
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on February 08, 2021 20:45 / Updated on May 05, 2021 20:32